Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 720 entries
Sorted by: Best Match Show Resources per page
The role of microRNA in tumorigenesis: key players or innocent bystanders.

Journal of surgical oncology

Sini RA, Trink B, Nissan A.
PMID: 19072979
J Surg Oncol. 2009 Mar 01;99(3):135-6. doi: 10.1002/jso.21213.

No abstract available.

Cite
Sini RA, Trink B, Nissan A. The role of microRNA in tumorigenesis: key players or innocent bystanders. J Surg Oncol. 2009;99(3):135-6doi: 10.1002/jso.21213.
Sini, R. A., Trink, B., & Nissan, A. (2009). The role of microRNA in tumorigenesis: key players or innocent bystanders. Journal of surgical oncology, 99(3), 135-6. https://doi.org/10.1002/jso.21213
Sini, Raneen Abu, et al. "The role of microRNA in tumorigenesis: key players or innocent bystanders." Journal of surgical oncology vol. 99,3 (2009): 135-6. doi: https://doi.org/10.1002/jso.21213
Sini RA, Trink B, Nissan A. The role of microRNA in tumorigenesis: key players or innocent bystanders. J Surg Oncol. 2009 Mar 01;99(3):135-6. doi: 10.1002/jso.21213. PMID: 19072979.
Copy Download .nbib Format: NLM
Emerging paradigms in cancer genetics: some important findings from high-density single nucleotide polymorphism array studies.

Cancer research

Bacolod MD, Schemmann GS, Giardina SF, Paty P, Notterman DA, Barany F.
PMID: 19155292
Cancer Res. 2009 Feb 01;69(3):723-7. doi: 10.1158/0008-5472.CAN-08-3543. Epub 2009 Jan 20.

High-density single nucleotide polymorphism (SNP) mapping arrays have identified chromosomal features whose importance to cancer predisposition and progression is not yet clearly defined. Of interest is that the genomes of normal somatic cells (reflecting the combined parental germ-line contributions)...

Cite
Bacolod MD, Schemmann GS, Giardina SF, et al. Emerging paradigms in cancer genetics: some important findings from high-density single nucleotide polymorphism array studies. Cancer Res. 2009;69(3):723-7doi: 10.1158/0008-5472.CAN-08-3543.
Bacolod, M. D., Schemmann, G. S., Giardina, S. F., Paty, P., Notterman, D. A., & Barany, F. (2009). Emerging paradigms in cancer genetics: some important findings from high-density single nucleotide polymorphism array studies. Cancer research, 69(3), 723-7. https://doi.org/10.1158/0008-5472.CAN-08-3543
Bacolod, Manny D, et al. "Emerging paradigms in cancer genetics: some important findings from high-density single nucleotide polymorphism array studies." Cancer research vol. 69,3 (2009): 723-7. doi: https://doi.org/10.1158/0008-5472.CAN-08-3543
Bacolod MD, Schemmann GS, Giardina SF, Paty P, Notterman DA, Barany F. Emerging paradigms in cancer genetics: some important findings from high-density single nucleotide polymorphism array studies. Cancer Res. 2009 Feb 01;69(3):723-7. doi: 10.1158/0008-5472.CAN-08-3543. Epub 2009 Jan 20. PMID: 19155292; PMCID: PMC4378658.
Copy Download .nbib Format: NLM
Religiosity, spirituality, and psychological distress in African-Americans at risk for having a hereditary cancer predisposing gene mutation.

American journal of medical genetics. Part C, Seminars in medical genetics

Kinney AY, Coxworth JE, Simonson SE, Fanning JB.
PMID: 19170079
Am J Med Genet C Semin Med Genet. 2009 Feb 15;151(1):13-21. doi: 10.1002/ajmg.c.30194.

Elevated psychological distress has been observed among people at increased risk for familial cancer. Researchers consider religiosity and spirituality (RS) to be positive coping mechanisms associated with reduced psychological distress. Relatively little is known about the impact of RS...

Cite
Kinney AY, Coxworth JE, Simonson SE, et al. Religiosity, spirituality, and psychological distress in African-Americans at risk for having a hereditary cancer predisposing gene mutation. Am J Med Genet C Semin Med Genet. 2009;151(1):13-21doi: 10.1002/ajmg.c.30194.
Kinney, A. Y., Coxworth, J. E., Simonson, S. E., & Fanning, J. B. (2009). Religiosity, spirituality, and psychological distress in African-Americans at risk for having a hereditary cancer predisposing gene mutation. American journal of medical genetics. Part C, Seminars in medical genetics, 151(1), 13-21. https://doi.org/10.1002/ajmg.c.30194
Kinney, Anita Y, et al. "Religiosity, spirituality, and psychological distress in African-Americans at risk for having a hereditary cancer predisposing gene mutation." American journal of medical genetics. Part C, Seminars in medical genetics vol. 151,1 (2009): 13-21. doi: https://doi.org/10.1002/ajmg.c.30194
Kinney AY, Coxworth JE, Simonson SE, Fanning JB. Religiosity, spirituality, and psychological distress in African-Americans at risk for having a hereditary cancer predisposing gene mutation. Am J Med Genet C Semin Med Genet. 2009 Feb 15;151(1):13-21. doi: 10.1002/ajmg.c.30194. PMID: 19170079; PMCID: PMC3040977.
Copy Download .nbib Format: NLM
Subgroup-specific associations in the face of overall null results: should we rush in or fear to tread?.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Weiss NS.
PMID: 18559544
Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1297-9. doi: 10.1158/1055-9965.EPI-08-0144.

No abstract available.

Cite
Weiss NS. Subgroup-specific associations in the face of overall null results: should we rush in or fear to tread?. Cancer Epidemiol Biomarkers Prev. 2008;17(6):1297-9doi: 10.1158/1055-9965.EPI-08-0144.
Weiss, N. S. (2008). Subgroup-specific associations in the face of overall null results: should we rush in or fear to tread?. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 17(6), 1297-9. https://doi.org/10.1158/1055-9965.EPI-08-0144
Weiss, Noel S. "Subgroup-specific associations in the face of overall null results: should we rush in or fear to tread?." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology vol. 17,6 (2008): 1297-9. doi: https://doi.org/10.1158/1055-9965.EPI-08-0144
Weiss NS. Subgroup-specific associations in the face of overall null results: should we rush in or fear to tread?. Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1297-9. doi: 10.1158/1055-9965.EPI-08-0144. PMID: 18559544.
Copy Download .nbib Format: NLM
Abstracts of the 12th International Meeting on Psychosocial Aspects of Hereditary Cancer (IMPAHC). April 27-29, 2011. Amsterdam, The Netherlands.

Familial cancer

[No authors listed]
PMID: 21479891
Fam Cancer. 2011 Apr;10:S70-97. doi: 10.1007/s10689-011-9430-5.

No abstract available.

Cite
Abstracts of the 12th International Meeting on Psychosocial Aspects of Hereditary Cancer (IMPAHC). April 27-29, 2011. Amsterdam, The Netherlands. Fam Cancer. 2011;10:S70-97doi: 10.1007/s10689-011-9430-5.
(2011). Abstracts of the 12th International Meeting on Psychosocial Aspects of Hereditary Cancer (IMPAHC). April 27-29, 2011. Amsterdam, The Netherlands. Familial cancer, 10S70-97. https://doi.org/10.1007/s10689-011-9430-5
"Abstracts of the 12th International Meeting on Psychosocial Aspects of Hereditary Cancer (IMPAHC). April 27-29, 2011. Amsterdam, The Netherlands." Familial cancer vol. 10 (2011): S70-97. doi: https://doi.org/10.1007/s10689-011-9430-5
Abstracts of the 12th International Meeting on Psychosocial Aspects of Hereditary Cancer (IMPAHC). April 27-29, 2011. Amsterdam, The Netherlands. Fam Cancer. 2011 Apr;10:S70-97. doi: 10.1007/s10689-011-9430-5. PMID: 21479891.
Copy Download .nbib Format: NLM
Down's syndrome: protection against cancer and the therapeutic potential of DSCR1.

Future oncology (London, England)

Ryeom S, Baek KH, Zaslavsky A.
PMID: 19852730
Future Oncol. 2009 Oct;5(8):1185-8. doi: 10.2217/fon.09.88.

No abstract available.

Cite
Ryeom S, Baek KH, Zaslavsky A. Down's syndrome: protection against cancer and the therapeutic potential of DSCR1. Future Oncol. 2009;5(8):1185-8doi: 10.2217/fon.09.88.
Ryeom, S., Baek, K. H., & Zaslavsky, A. (2009). Down's syndrome: protection against cancer and the therapeutic potential of DSCR1. Future oncology (London, England), 5(8), 1185-8. https://doi.org/10.2217/fon.09.88
Ryeom, Sandra, et al. "Down's syndrome: protection against cancer and the therapeutic potential of DSCR1." Future oncology (London, England) vol. 5,8 (2009): 1185-8. doi: https://doi.org/10.2217/fon.09.88
Ryeom S, Baek KH, Zaslavsky A. Down's syndrome: protection against cancer and the therapeutic potential of DSCR1. Future Oncol. 2009 Oct;5(8):1185-8. doi: 10.2217/fon.09.88. PMID: 19852730.
Copy Download .nbib Format: NLM
Exploring genetic susceptibility to cancer in diverse populations.

Current opinion in genetics & development

Haiman CA, Stram DO.
PMID: 20359883
Curr Opin Genet Dev. 2010 Jun;20(3):330-5. doi: 10.1016/j.gde.2010.02.007. Epub 2010 Mar 30.

Incidence rates for many cancers differ markedly by race/ethnicity and furthering our understanding of the genetic and environmental causes of such disparities is a scientific and public health need. Genome-wide association studies (GWAS) are widely acknowledged to provide important...

Cite
Haiman CA, Stram DO. Exploring genetic susceptibility to cancer in diverse populations. Curr Opin Genet Dev. 2010;20(3):330-5doi: 10.1016/j.gde.2010.02.007.
Haiman, C. A., & Stram, D. O. (2010). Exploring genetic susceptibility to cancer in diverse populations. Current opinion in genetics & development, 20(3), 330-5. https://doi.org/10.1016/j.gde.2010.02.007
Haiman, Christopher A, and Stram, Daniel O. "Exploring genetic susceptibility to cancer in diverse populations." Current opinion in genetics & development vol. 20,3 (2010): 330-5. doi: https://doi.org/10.1016/j.gde.2010.02.007
Haiman CA, Stram DO. Exploring genetic susceptibility to cancer in diverse populations. Curr Opin Genet Dev. 2010 Jun;20(3):330-5. doi: 10.1016/j.gde.2010.02.007. Epub 2010 Mar 30. PMID: 20359883; PMCID: PMC4196678.
Copy Download .nbib Format: NLM
[Contribution to the role of heredity in the etiology of cancer].

Biulleten' eksperimental'noi biologii i meditsiny

MARTYNOVA RP.
PMID: 21008509
Biull Eksp Biol Med. 1945;19(3):12-5.

No abstract available.

Cite
MARTYNOVA RP. [Contribution to the role of heredity in the etiology of cancer]. Biull Eksp Biol Med. 1945;19(3):12-5
MARTYNOVA, R. P. (1945). [Contribution to the role of heredity in the etiology of cancer]. Biulleten' eksperimental'noi biologii i meditsiny, 19(3), 12-5.
MARTYNOVA, R P. "[Contribution to the role of heredity in the etiology of cancer]." Biulleten' eksperimental'noi biologii i meditsiny vol. 19,3 (1945): 12-5.
MARTYNOVA RP. [Contribution to the role of heredity in the etiology of cancer]. Biull Eksp Biol Med. 1945;19(3):12-5. PMID: 21008509.
Copy Download .nbib Format: NLM
OMIT: a domain-specific knowledge base for microRNA target prediction.

Pharmaceutical research

Huang J, Townsend C, Dou D, Liu H, Tan M.
PMID: 21879385
Pharm Res. 2011 Dec;28(12):3101-4. doi: 10.1007/s11095-011-0573-8. Epub 2011 Aug 31.

Identification and characterization of the important roles microRNAs (miRNAs) perform in human cancer is an increasingly active research area. Unfortunately, prediction of miRNA target genes remains a challenging task to cancer researchers. Current processes are time-consuming, error-prone, and subject...

Cite
Huang J, Townsend C, Dou D, et al. OMIT: a domain-specific knowledge base for microRNA target prediction. Pharm Res. 2011;28(12):3101-4doi: 10.1007/s11095-011-0573-8.
Huang, J., Townsend, C., Dou, D., Liu, H., & Tan, M. (2011). OMIT: a domain-specific knowledge base for microRNA target prediction. Pharmaceutical research, 28(12), 3101-4. https://doi.org/10.1007/s11095-011-0573-8
Huang, Jingshan, et al. "OMIT: a domain-specific knowledge base for microRNA target prediction." Pharmaceutical research vol. 28,12 (2011): 3101-4. doi: https://doi.org/10.1007/s11095-011-0573-8
Huang J, Townsend C, Dou D, Liu H, Tan M. OMIT: a domain-specific knowledge base for microRNA target prediction. Pharm Res. 2011 Dec;28(12):3101-4. doi: 10.1007/s11095-011-0573-8. Epub 2011 Aug 31. PMID: 21879385.
Copy Download .nbib Format: NLM
MicroRNA expression profiling in cancer from a bioinformatics prospective.

Expert review of molecular diagnostics

Gusev Y, Brackett DJ.
PMID: 18020908
Expert Rev Mol Diagn. 2007 Nov;7(6):787-92. doi: 10.1586/14737159.7.6.787.

A new type of noncoding short single-stranded RNA molecules, microRNA (miRNA), has recently emerged as one of the most important new classes of cellular regulators. Recent advances in miRNA research have provided evidence that aberrant expression of specific miRNAs...

Cite
Gusev Y, Brackett DJ. MicroRNA expression profiling in cancer from a bioinformatics prospective. Expert Rev Mol Diagn. 2007;7(6):787-92doi: 10.1586/14737159.7.6.787.
Gusev, Y., & Brackett, D. J. (2007). MicroRNA expression profiling in cancer from a bioinformatics prospective. Expert review of molecular diagnostics, 7(6), 787-92. https://doi.org/10.1586/14737159.7.6.787
Gusev, Yuriy, and Brackett, Daniel J. "MicroRNA expression profiling in cancer from a bioinformatics prospective." Expert review of molecular diagnostics vol. 7,6 (2007): 787-92. doi: https://doi.org/10.1586/14737159.7.6.787
Gusev Y, Brackett DJ. MicroRNA expression profiling in cancer from a bioinformatics prospective. Expert Rev Mol Diagn. 2007 Nov;7(6):787-92. doi: 10.1586/14737159.7.6.787. PMID: 18020908.
Copy Download .nbib Format: NLM
Molecular imaging: current status and emerging strategies.

Clinical radiology

Pysz MA, Gambhir SS, Willmann JK.
PMID: 20541650
Clin Radiol. 2010 Jul;65(7):500-16. doi: 10.1016/j.crad.2010.03.011.

In vivo molecular imaging has a great potential to impact medicine by detecting diseases in early stages (screening), identifying extent of disease, selecting disease- and patient-specific treatment (personalized medicine), applying a directed or targeted therapy, and measuring molecular-specific effects...

Cite
Pysz MA, Gambhir SS, Willmann JK. Molecular imaging: current status and emerging strategies. Clin Radiol. 2010;65(7):500-16doi: 10.1016/j.crad.2010.03.011.
Pysz, M. A., Gambhir, S. S., & Willmann, J. K. (2010). Molecular imaging: current status and emerging strategies. Clinical radiology, 65(7), 500-16. https://doi.org/10.1016/j.crad.2010.03.011
Pysz, M A, et al. "Molecular imaging: current status and emerging strategies." Clinical radiology vol. 65,7 (2010): 500-16. doi: https://doi.org/10.1016/j.crad.2010.03.011
Pysz MA, Gambhir SS, Willmann JK. Molecular imaging: current status and emerging strategies. Clin Radiol. 2010 Jul;65(7):500-16. doi: 10.1016/j.crad.2010.03.011. PMID: 20541650; PMCID: PMC3150531.
Copy Download .nbib Format: NLM
Data mining using the Catalogue of Somatic Mutations in Cancer BioMart.

Database : the journal of biological databases and curation

Shepherd R, Forbes SA, Beare D, Bamford S, Cole CG, Ward S, Bindal N, Gunasekaran P, Jia M, Kok CY, Leung K, Menzies A, Butler AP, Teague JW, Campbell PJ, Stratton MR, Futreal PA.
PMID: 21609966
Database (Oxford). 2011 May 23;2011:bar018. doi: 10.1093/database/bar018. Print 2011.

Catalogue of Somatic Mutations in Cancer (COSMIC) (http://www.sanger.ac.uk/cosmic) is a publicly available resource providing information on somatic mutations implicated in human cancer. Release v51 (January 2011) includes data from just over 19,000 genes, 161,787 coding mutations and 5573 gene...

Cite
Shepherd R, Forbes SA, Beare D, et al. Data mining using the Catalogue of Somatic Mutations in Cancer BioMart. Database (Oxford). 2011;2011:bar018doi: 10.1093/database/bar018.
Shepherd, R., Forbes, S. A., Beare, D., Bamford, S., Cole, C. G., Ward, S., Bindal, N., Gunasekaran, P., Jia, M., Kok, C. Y., Leung, K., Menzies, A., Butler, A. P., Teague, J. W., Campbell, P. J., Stratton, M. R., & Futreal, P. A. (2011). Data mining using the Catalogue of Somatic Mutations in Cancer BioMart. Database : the journal of biological databases and curation, 2011bar018. https://doi.org/10.1093/database/bar018
Shepherd, Rebecca, et al. "Data mining using the Catalogue of Somatic Mutations in Cancer BioMart." Database : the journal of biological databases and curation vol. 2011 (2011): bar018. doi: https://doi.org/10.1093/database/bar018
Shepherd R, Forbes SA, Beare D, Bamford S, Cole CG, Ward S, Bindal N, Gunasekaran P, Jia M, Kok CY, Leung K, Menzies A, Butler AP, Teague JW, Campbell PJ, Stratton MR, Futreal PA. Data mining using the Catalogue of Somatic Mutations in Cancer BioMart. Database (Oxford). 2011 May 23;2011:bar018. doi: 10.1093/database/bar018. Print 2011. PMID: 21609966; PMCID: PMC3263736.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 720 entries